← FDA Drug Approvals (Drugs@FDA)
CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMACEUTICALS LTD · Approved 2025-10-01
Drug application
- FDA Application #
ANDA215255- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- Generic name
- Metformin Hydrochloride
- Active ingredients
- METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- MACLEODS PHARMACEUTICALS LTD
- First approval
- 2025-10-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown